Leukemia Therapeutics Market

Published on 2023-02-03

Report Code: 571

170-350 pages

Leukemia Therapeutics Market: By Type (Chronic Myeloid, Chronic Lymphocytic, Acute Lymphocytic, Acute Myeloid, Others), By Route of Administration (Oral, Injectable), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Others), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032

Buy Now

Add to cart

Table Of Content

1 Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Leukemia Therapeutics Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot

2 Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation

3 Market Characteristics
3.1. Market Definition
3.2. Leukemia Therapeutics Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4 Leukemia Therapeutics Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5 Macroeconomic Indicators

6 Recent Developments

7 Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends

8 Risk Analysis

9 Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological

10 Leukemia Therapeutics Market
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11 Leukemia Therapeutics Market Size & Forecast 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Type
11.3.1.1. Chronic Myeloid
11.3.1.1.1 By Value (USD Million) 2022-2032F
11.3.1.1.2 Market Share (%) 2022-2032F
11.3.1.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Chronic Lymphocytic
11.3.1.2.1 By Value (USD Million) 2022-2032F
11.3.1.2.2 Market Share (%) 2022-2032F
11.3.1.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Acute Lymphocytic
11.3.1.3.1 By Value (USD Million) 2022-2032F
11.3.1.3.2 Market Share (%) 2022-2032F
11.3.1.3.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Acute Myeloid
11.3.1.4.1 By Value (USD Million) 2022-2032F
11.3.1.4.2 Market Share (%) 2022-2032F
11.3.1.4.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.5. Others
11.3.1.5.1 By Value (USD Million) 2022-2032F
11.3.1.5.2 Market Share (%) 2022-2032F
11.3.1.5.3 Y-o-Y Growth (%) 2022-2032F
11.3.2. By Route of Administration
11.3.2.1. Oral
11.3.2.1.1 By Value (USD Million) 2022-2032F
11.3.2.1.2 Market Share (%) 2022-2032F
11.3.2.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Injectable
11.3.2.2.1 By Value (USD Million) 2022-2032F
11.3.2.2.2 Market Share (%) 2022-2032F
11.3.2.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.3. By Treatment Type
11.3.3.1. Chemotherapy
11.3.3.1.1 By Value (USD Million) 2022-2032F
11.3.3.1.2 Market Share (%) 2022-2032F
11.3.3.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Targeted Therapy
11.3.3.2.1 By Value (USD Million) 2022-2032F
11.3.3.2.2 Market Share (%) 2022-2032F
11.3.3.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Immunotherapy
11.3.3.3.1 By Value (USD Million) 2022-2032F
11.3.3.3.2 Market Share (%) 2022-2032F
11.3.3.3.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1 By Value (USD Million) 2022-2032F
11.3.3.4.2 Market Share (%) 2022-2032F
11.3.3.4.3 Y-o-Y Growth (%) 2022-2032F

12 North America Leukemia Therapeutics Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2. By Route of Administration
12.3.3. By Treatment Type
12.4. Country
12.4.1. United States
12.4.2. Canada

13 Europe Leukemia Therapeutics Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2. By Route of Administration
13.3.3. By Treatment Type
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14 Asia Leukemia Therapeutics Market Size & Forecast 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2. By Route of Administration
14.3.3. By Treatment Type
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC

15 Middle East and Africa Leukemia Therapeutics Market Size & Forecast 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2. By Route of Administration
15.3.3. By Treatment Type
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa

16 Latin America Leukemia Therapeutics Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2. By Route of Administration
16.3.3. By Treatment Type
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America

17 Competitive Landscape
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders

18 Company Profiles
18.1. Johnson & Johnson
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3 Market Share
18.1.4.4 Recent News & Development (Last 3 Yrs.)
18.1.4.5 Executive Team
18.2. Novartis
18.3. Hoffmann-La Roche
18.4. Sanofi
18.5. GlaxoSmithKline Plc
18.6. Pfizer
18.7. AbbVie
18.8. Novartis Pharmaceuticals
18.9. Takeda Pharmaceutical
18.10. Bristol-Myers Squibb
18.11. Amgen
18.12. Daiichi Sankyo
18.13. Gilead Sciences
18.14. Eisai C.
18.15. Incyte Corp
18.16. Other Prominent Players